News
The San Diego, USA firm has simultaneously announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...
RNA-binding proteins use a dual binding mechanism involving zinc finger (ZnF) domains and intrinsically disordered regions ...
Messenger RNA, or mRNA – a technology that can instruct cells to fight disease – has fueled breakthroughs from Covid vaccines ...
Zacks Investment Research on MSN19h
RNA Stock Moves More Than 30% in a Week: What's Driving This Rally?
Shares of Avidity Biosciences RNA have soared 36% in the past month, all thanks to a report issued by the Financial Times (FT ...
The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...
Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...
Arnatar Therapeutics, a biotechnology company pioneering RNA-based therapies for severe and underserved diseases, emerges from stealth today and announces that the U.S. Food and Drug Administration ...
Certain types of biochemical processes can impair the immune system’s ability to recognize and kill cancer cells. Purdue ...
A recent study developed a highly accurate risk prediction framework for preterm birth (PTB) that could broaden the potential ...
From Johns Hopkins University School of Medicine, Charlotte J. Sumner, M.D., presents an editorial on a study by Richard S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback